Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients

NCT03452293 is registered in ClinicalTrials.gov with EndoCore Lab s.r.l. as lead sponsor.

NCT NCT03452293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03452293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
Lead sponsor
EndoCore Lab s.r.l.
Phase
Observational
Overall status
Completed
Start date
March 7, 2018
Completion date
March 28, 2022
Enrollment
92 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pad